INTRODUCTION
Platelets play an important role in maintaining the integrity of the blood vessels and control bleeding by forming blood clots, but they known to be involved in the thrombosis pathogenesis includes adhering to the vessel injury site, aggregate to form a hemostatic plug or thrombus, and the coagulation cascade acceleration that leads to the thrombosis formation. 1 Thrombosis means localized clotting of the blood, which can take place within the arterial or the venous circulation and contains a significant medical impact. 2 Thrombus formed in the circulatory system due to the loss of hemostasis causes vascular blockage, atherothrombotic sicknesses, myocardial or cerebral localized necrosis ultimately prompting death. 3 The hemostatic process regulation may be a promising approach for the thrombosis prevention or treatment. The development of antithrombotic agents with safer and efficient, including from natural product, is the goal of tremendous pharmaceutical efforts. 4 Ginger and sappan are examples of herb that has been found in the daily food, drink and widely used as a traditional medicine in Indonesia. Ginger and sappan have been used since kingdom era in Java Island, Indonesia as a health drink and also as herbal medicine to ease cough. 5, 6 Chemically, bioactive components isolated from ginger, 6-gingerol and 6-shogaol in ginger have shown to have a pharmacological activities, such as antitussive, analgesic, hypotensive effects, antioxidant, anticancer, anti-inflammatory, and anti-peptic ulcer. [7] [8] [9] Wood core of sappan contains several aromatic compounds, brazilin, sappan chalcone, Caesalpinia J, caesalpin P, protosappanin A, B protosappanin, homoisoflavonoids ß-sitosterol. 10 This study investigated whether the combination of ginger and sappan extract has antithrombotic properties using in vivo experimental model.
MATERIALS AND METHODS

Extract and Chemicals
The test materials used are a readily used water extract of Caesalpinia sappan L. and ethanol extract of Zingiber officinale Rosc. obtained from Java plant. Water extract of Caesalpinia sappan L. that is used contains Brazilin and ethanol extract of Zingiber officinale Rosc. contains 2% gingerol. Collagen and epinephrine were purchased from Sigma-Aldrich (United State).
Animals
The animal used in the test is male DDY (Deutschland, Denken, and Yoken) mice purchased from Institut Pertanian Bogor (IPB). The study has been approved by Health Research Ethics Committees of Faculty of Medicine, Universitas Indonesia (Number: 377/UN2.F1/ETIK/2016).
Thromboembolism Mouse Models
The antithrombotic activity of ginger and sappan extract combination was determined by using pulmonary thrombosis test in the mouse as well as described in DiMinno's method with slight modification. 11 In brief, combination of ginger and sappan extract in three variants of dose (28 mg : 7 mg/20 g; 56 mg : 14 mg/20 g; 112 mg : 28 mg/20 g) were orally administered as a pretreatment prior to induction. Aspirin (80 mg/kg) as a positive control were given once per day for 7 days to DDY mice (20-30g). 24 hr after final oral administration of the samples, all groups were induced pulmonary thrombosis by using a solution contain collagen (520 μg/mouse) and epinephrine (6.5 μg/mouse). The mixture solution Journal of Young Pharmacists, Vol 9, Issue 1(Suppl), Jan-Mar, 2017
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was injected into the tail vein of each mouse. The paralyzed mice were observed and the number of dead mice was counted within 15 min. The survival rate in percentage (%) was calculated with the following equation: [1−(dead or paralyzed mice)/total mice tested]×100. 12 
Bleeding Time Test
Mice are anesthetized with ketamine (each dose of 100 mg / kg BW). Mice are placed in a horizontal position. About 10-mm segment of the tail is amputated. Then, the tail immediately immersed in a 50 mL Falcon tubes containing saline (0.9%) at a temperature of 37 o C. The tail is positioned vertically, but the tip is about 2 cm below the body horizontally. Each mouse is monitored for 20 minutes. Although the bleeding stops before 20 minutes, monitoring is still being done to detect the presence of re-bleeding. The bleeding time is calculated by the stopwatch. If bleeding occurs is not constant (missing/signage), the data used is the bleeding accumulated data within 20 minutes. The experiment is discontinued after 20 minutes to prevent the death of test mice during experiments. 13 The bleeding time percentage by the ginger -sappan extract obtained from the comparison with the normal control group.
Data Analysis
Bleeding time obtained from each treatment group are then processed statistically. First, data normality was tested by the Shapiro-Wilk test, the results obtained are normally distributed data. Then, the data homogeneity was tested by Levene test, but the results obtained are no data distributed homogeneously, so as to test whether there is a significant difference in the overall data, non-parametric method is used, namely Kruskal-Wallis test whether there is a significant difference in the overall data and the Mann-Whitney test to test whether there is a significant difference between the treatment groups.
RESULTS
Observation Result of Bleeding Time
The calculation result of the average time of bleeding time can be seen in Table 1 . A normal control group that is given CMC has the average bleeding time of 11.65 ± 0.877 min. A positive control group that has been given Aspirin has the average bleeding time of 18.75 ± 0.533 min, which is significantly different (p ≤ 0.05) compared to normal control group. Ginger -sappan wood extract groups dose I, II, and III have the average bleeding time of 12.49 ± 1.813; 15.80 ± 1.070; and 13.89 ± 1.827 min, consecutively. Based on the analysis data, out of these three extract groups, dose II group showed a significant difference in bleeding time prolongation compared with normal control group.
Calculation Result of Survival Rate
Survival rate calculation results obtained from each group after treatment that can be seen in Table 2 . Based on the calculation result, normal control group and the positive control group showed 100% survival rate which means 6 out of 6 mice are alive. The negative control group showed a survival rate of 16.67% or 1 out of 6 mice is alive. Ginger -sappan wood extract groups dose I, II, and III have a survival rate of 50% (3 out of 6 mice are alive); 83.33% (5 out of 6 mice are alive); and 66.67% (4 out of 6 mice are alive), consecutively.
DISCUSSION
Bleeding Time Analysis
Based on the result, a combination of ginger-sappan extract in various dosage levels can increase the bleeding time. However, statistically, the increase of bleeding time that was significantly different (p ≤ 0.05) compared to the normal control only occurs at a dose of 56 mg : 14 mg/20 g. Extended bleeding time is due to inhibition of platelet activation and aggregation caused by compounds such as arachidonic acid, thrombin, collagen, ADP (adenosine diphosphate), thromboxane, serotonin, and COX-1 by gingerol and brazilin which are the active components of ginger and sappan.
14 Inhibition of platelet activation and aggregation can prevent thrombus formation so as to facilitate the circulation of blood. The bleeding time at dose of 112 mg : 28 mg/20 g and 28 mg : 7 mg/20 g were not extended significantly (p ≥ 0.05) will likely be due to dose of 112 mg : 28 mg/20 g and 28 mg : 7 mg/20 g were not included in the optimal dose range of ginger and sappan as an antithrombotic agent. A research on the antiplatelet effect of the constituents of ginger indicates that inhibition of platelet aggregation activity undertaken of a constituent will be different at certain concentrations. The study shows that the constituents started to show inhibitory activity at a concentration of 0.1 µg / ml, but the majority of the constituents work optimally in inhibiting platelet aggregation in the concentration range of 100 µg / ml. One example is [6] -gingerol that works optimally in inhibiting platelet aggregation induced by collagen and arachidonic acid at concentrations of 20 and 1 µg / ml, whereas [6] -shaogaol work optimally inhibit platelet aggregation induced by collagen and arachidonic acid at a concentration 5 and 1 mg / ml. Although the inhibitory activity also occurs at lower doses and high- #: Significantly different (p ≤ 0.05) with normal controls er, but the results are not as good as optimal dose. 15 Some constituents of ginger as gingerol, shogaol and paradol inhibit the activity of COX-1 and collagen, a constituent sappan namely brazilin also shows the inhibitory activity of platelet aggregation induced by collagen and ADP (adenosine diphosphate) in which these activities are also shown by aspirin used as a positive control in this study. 14, 15 This shows the potential constituents of ginger and sappan have the same activity as aspirin that also works optimally at a certain dose. Research conducted by Gan, Teleg, Florento, & Bitanga in 2002 16 showed that aspirin has inhibitory activity of platelet aggregation induced by collagen in a dose-dependent ranging from 40 mg / day, but works optimally at a dose of 80-160 mg / day, while the inhibitory activity ADP-induced platelet aggregation (adenosine diphosphate) are shown up to a dose of 1300 mg / day. 15 Optimal inhibition of COX-1 by aspirin was shown at doses 81 mg / day. 17 
Survival Rate Calculation
Based on the calculation result of the survival rate, a dose of 56 mg: 14 mg/20 g also showed a higher result compared to the two other doses, although two other doses also have a higher survival rate than the negative control. Dose II group had a survival rate of 83.33%, which there are 5 of 6 mice survival after thrombosis induction. In addition to the possibility of ginger-sappan extract have the same activity as aspirin that works optimally in certain range of dose, the results of the survival rate of a dose of 56 mg : 14 mg/20 g better than a dose of 112 mg : 28 mg/20 g and 28 mg : 7 mg/20 g may be due to a dose of 56 mg : 14 mg/20 g was included in certain range of dose that is working optimally in inhibiting platelet aggregation induced by collagen and epinephrine. 18 Additionally, it also may be due to the active compound of sappan and ginger have a narrow therapeutic window, so that the optimal results actually indicated on the mid dose or dose of 56 mg: 14 mg/20 g, not at a dose of 112 mg : 28 mg/20 g and 28 mg : 7 mg/20 g. At the dose 28 mg: 7 mg/20 g, it is likely the combination of extracts has not reached the minimum concentration drugs to give a therapeutic effect (minimum effective concentration). Then at dose 112 mg: 28 mg/20 g, the combination of extracts may have reached the minimum concentration of the drug to produce toxic effects (toxicity minimum concentration), then the bleeding time and survival rate of the dose of 112 mg: 28 mg/20 g and 28 mg: 7 mg/20 g are lower than dose of 56 mg : 14 mg/20 g.
CONCLUSION
The combination of ginger-sappan wood extract has potential as antithrombotic drugs because it can increase bleeding time and survival rate of test mice at a dose ratio of ginger-sappan wood 56 mg: 14 mg / 20 g BB. However, further research is needed to determine the optimum dose and administration duration of ginger-sappanwood extract by increasing the dose starting from the optimal dose from this research gradually and extending the duration of administration.
